HomePLX • NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.59
Apr 16, 3:59:49 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
StockUS listed securityIL headquartered
Previous close
$2.62
Day range
$2.55 - $2.63
Year range
$0.82 - $2.76
Market cap
201.71M USD
Avg Volume
737.17K
P/E ratio
71.61
Dividend yield
-
Market news
About
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
Founded
1993
Employees
213
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu